Surmodics | 税前利润

金融业

USD

USD 178.56M

现金及等价物

USD 36.12M

USD 33.03M

USD 81.3M

USD 20.54M

USD 29.55M

股息收益率

0

USD -322K

USD 1.53M

376

EPS每股收益

USD -0.25

股本和储备

USD 118.9M

USD -11.54M

债务利息支出

USD 884K

USD 29.55M

USD 393.5M

USD -11.54M

USD -245.35M

USD -5.65M

普通股股本

USD 716K

386.18

USD -7.51M

USD 29.92M

销售和管理费用

USD 14.58M

USD 15.17M

贸易债权人

USD 2.79M

应收帐款人

USD 23.27M

	税前利润	更改		日
Abbott	USD 2.36B		178M	2025-12
Align Technology	USD 176.6M		81.86M	2025-12
Anika Therapeutics	USD -3.87M		32.43M	2025-03
Arrowhead Research	USD 28.27M		7.85M	2025-12
Artivion	USD -1.27M		1.16M	2024-09
Baxter International	USD 121M		12M	2025-09
Boston Scientific	USD 938M		3M	2025-09
EDAP TMS	EUR -4.91M		597K	2025-09
Edwards Lifesciences	USD 348.4M		51.8M	2025-09
Haemonetics	USD 59.97M		8.69M	2025-12
Heron Therapeutics	USD -4.85M		4.39M	2024-09
J&J	USD 4.97B		2.53B	2025-12
Merit Medical Systems	USD 73.18M		29.8M	2025-09
Mesa Laboratories	USD -2.22M		6.03M	2024-12
Nektar Therapeutics	USD -37.05M		15.27M	2024-09
Option Care Health	USD 68.97M		109K	2025-09
Stryker	USD 1.03B		13M	2025-09
Surmodics	USD -7.51M		1.69M	2024-09
Trinity Biotech	USD -5.06M		10.74M	2025-09

Surmodics 税前利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.